Drospirenone and estetrol

(Nextstellis®)

Drospirenone and estetrol

Drug updated on 1/4/2024

Dosage FormTablet (oral; drospirenone/estetrol 3 mg/14.2 mg)
Drug ClassContraceptives
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for use by females of reproductive potential to prevent pregnancy.

Product Monograph / Prescribing Information

Document TitleYearSource
Nextstellis (drospirenone and estetrol) Prescribing Information.2023Mayne Pharma, Greenville, NC

Randomized Controlled Trials


Sex Distribution:

F:100%
M:0%
1553Subjects

Year:

2022

Source:An International Journal of Obstetrics and Gynaecology